US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

C4 Therapeutics, Inc.

2.41

-0.2100-8.02%

Post-market: 2.470.0647+2.68%19:58 EDT

Volume:1.63M

Turnover:4.06M

Market Cap:235.16M

PE:-1.90

High:2.60

Open:2.57

Low:2.39

Close:2.62

52wk High:3.82

52wk Low:1.09

Shares:97.58M

Float Shares:72.05M

Volume Ratio:0.77

T/O Rate:2.27%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.2666

EPS(LYR):-1.2666

ROE:-44.44%

ROA:-18.43%

PB:0.92

PE(LYR):-1.90

Loading ...

Overview Company News Filings

C4 Therapeutics Showcases Progress on IKZF1/3 Degrader and Expanding Protein Degradation Pipeline

C4 Therapeutics Q3 EPS USD -0.44

C4 Therapeutics Q3 EPS $(0.44) Misses $(0.40) Estimate, Sales $11.230M Beat $6.280M Estimate

C4 Therapeutics Raises $125 Million and Reports Positive Phase 1 Cemsidomide Data

C4 Therapeutics: Expects Current Cash, Cash Equivalents & Marketable Securities Will Enable Co to Fund Its Operating Plan to End of 2028

THOMSON REUTERS

C4 Therapeutics Inc expected to post a loss of 40 cents a share - Earnings Preview

C4 Therapeutics Inc expected to post a loss of 40 cents a share - Earnings Preview

Point72 Asset Management Lp Reports 9.9% Passive Stake in C4 Therapeutics as of Oct 17 - SEC Filing

THOMSON REUTERS

C4 Therapeutics prices $125M underwritten offering

C4 Therapeutics Announces $125 Million Underwritten Offering with Potential to Raise Up to $349.7 Million Through Stock and Warrant Sales

C4 Therapeutics Inc - Proceeds Could Reach $349.7 Mln IF All Warrants Exercised

THOMSON REUTERS

Press Release: C4 Therapeutics Announces Pricing of $125 Million Underwritten Offering

C4 Therapeutics Presents Phase 1 Trial Data

C4 Therapeutics Showcases Pipeline Progress and Highlights Potential of Cemsidomide and Next-Generation Degrader Programs

BUZZ-C4 Therapeutics climbs after partnership with Pfizer for cancer therapy trial

C4 Therapeutics announces trial collab, supply agreement with Pfizer

C4 Therapeutics Announces Clinical Trial Collaboration with Pfizer to Combine Cemsidomide and Elranatamab for Multiple Myeloma Treatment

C4 Therapeutics Inc - Pfizer to Supply Elranatamab at No Cost; C4t to Conduct Trial

THOMSON REUTERS

C4 Therapeutics Announces Clinical Trial Collaboration and Supply Agreement With Pfizer for the Combination of Cemsidomide and Elranatamab for the Treatment of Relapsed/Refractory Multiple Myeloma

THOMSON REUTERS

CCCC Lisbon 2025 Announces Bybit EU and Top Partners as Sponsors of Its Third Global Edition

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CCCC/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CCCC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CCCC\",,,,,undefined,":{"symbol":"CCCC","market":"US","secType":"STK","nameCN":"C4 Therapeutics, Inc.","latestPrice":2.41,"timestamp":1774641600000,"preClose":2.62,"halted":0,"volume":1632747,"hourTrading":{"tag":"盘后","latestPrice":2.4747,"preClose":2.41,"latestTime":"19:58 EDT","volume":1414,"amount":3434.0176,"timestamp":1774655909114,"change":0.0647,"changeRate":0.026846,"amplitude":0.034855},"delay":0,"changeRate":-0.08015267175572517,"floatShares":72053500,"shares":97578175,"eps":-1.266598,"marketStatus":"Market Closed","change":-0.21,"latestTime":"03-27 16:00:00 EDT","open":2.57,"high":2.6,"low":2.39,"amount":4059602.3822598,"amplitude":0.080153,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.266598,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"listingDate":1601611200000,"exchange":"NASDAQ","adjPreClose":2.62,"preHourTrading":{"tag":"盘前","latestPrice":2.6,"preClose":2.62,"latestTime":"09:28 EDT","volume":1563,"amount":4110.6402966,"timestamp":1774618099025,"change":-0.02,"changeRate":-0.007634,"amplitude":0.015267},"postHourTrading":{"tag":"盘后","latestPrice":2.4747,"preClose":2.41,"latestTime":"19:58 EDT","volume":1414,"amount":3434.0176,"timestamp":1774655909114,"change":0.0647,"changeRate":0.026846,"amplitude":0.034855},"volumeRatio":0.767994,"impliedVol":1.3186,"impliedVolPercentile":0.6056},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CCCC\",,,,,undefined,":{"symbol":"CCCC","floatShares":72053500,"roa":"-18.43%","roe":"-44.44%","lyrEps":-1.266598,"volumeRatio":0.767994,"shares":97578175,"dividePrice":0,"high":2.6,"amplitude":0.080153,"preClose":2.62,"low":2.39,"week52Low":1.085,"pbRate":"0.92","psRate":"6.54","week52High":3.82,"institutionHeld":0,"latestPrice":2.41,"eps":-1.266598,"divideRate":0,"volume":1632747,"delay":0,"ttmEps":-1.266598,"open":2.57,"prevYearClose":1.91,"prevWeekClose":2.7,"prevMonthClose":2.7,"prevQuarterClose":1.91,"fiveDayClose":2.7,"twentyDayClose":2.7,"sixtyDayClose":1.96},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CCCC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-26","symbol":"CCCC","fiscalQuarterEnding":"2025/12","expectedEps":-0.43,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"pre","actualEps":-0.18},{"market":"US","date":"2025-11-06","symbol":"CCCC","fiscalQuarterEnding":"2025/09","expectedEps":-0.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.44},{"market":"US","date":"2025-08-07","symbol":"CCCC","fiscalQuarterEnding":"2025/06","expectedEps":-0.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.37},{"market":"US","date":"2025-05-07","symbol":"CCCC","fiscalQuarterEnding":"2025/03","expectedEps":-0.48,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"pre","actualEps":-0.37},{"market":"US","date":"2025-02-27","symbol":"CCCC","fiscalQuarterEnding":"2024/12","expectedEps":-0.44,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":-0.49}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CCCC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CCCC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.625,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1764734400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CCCC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CCCC","date":"2026-03-27","current":-1.902735,"percent":0.60049,"low":-29.298435,"twenty":-12.516333,"median":-3.00385,"eighty":-1.377071,"high":-0.441953,"avg":-6.411385,"sd":7.804853,"marketCap":255654818},"quantilePoints":[{"date":"2021-04-01","current":-25.110452,"twenty":-44.114079,"median":-44.114079,"eighty":-25.954537,"marketCap":1665701842},{"date":"2021-04-09","current":-21.229805,"twenty":-44.114079,"median":-44.114079,"eighty":-25.826049,"marketCap":1408279114},{"date":"2021-04-16","current":-21.158302,"twenty":-44.114079,"median":-44.114079,"eighty":-25.362035,"marketCap":1403535981},{"date":"2021-04-23","current":-19.864753,"twenty":-44.114079,"median":-44.114079,"eighty":-25.223209,"marketCap":1317728405},{"date":"2021-04-30","current":-21.552398,"twenty":-44.114079,"median":-44.114079,"eighty":-25.143505,"marketCap":1429678303},{"date":"2021-05-07","current":-22.320731,"twenty":-44.114079,"median":-44.114079,"eighty":-24.806946,"marketCap":1480645687},{"date":"2021-05-14","current":-19.96082,"twenty":-44.114079,"median":-35.913777,"eighty":-24.51893,"marketCap":1504926063},{"date":"2021-05-21","current":-20.843129,"twenty":-44.114079,"median":-34.62044,"eighty":-24.175784,"marketCap":1571446905},{"date":"2021-05-28","current":-21.169699,"twenty":-44.114079,"median":-33.847592,"eighty":-23.708555,"marketCap":1596068256},{"date":"2021-06-04","current":-22.367119,"twenty":-44.114079,"median":-33.54003,"eighty":-23.314514,"marketCap":1686346542},{"date":"2021-06-11","current":-24.166113,"twenty":-44.114079,"median":-33.409908,"eighty":-23.314514,"marketCap":1821979947},{"date":"2021-06-18","current":-23.856717,"twenty":-44.114079,"median":-33.208809,"eighty":-23.28874,"marketCap":1798653294},{"date":"2021-06-25","current":-24.068849,"twenty":-44.114079,"median":-32.913077,"eighty":-23.360173,"marketCap":1814646834},{"date":"2021-07-02","current":-25.331603,"twenty":-44.114079,"median":-32.822385,"eighty":-23.433348,"marketCap":1909850881},{"date":"2021-07-09","current":-24.502522,"twenty":-44.114079,"median":-32.688319,"eighty":-23.490373,"marketCap":1847343173},{"date":"2021-07-16","current":-25.478287,"twenty":-44.114079,"median":-32.305839,"eighty":-23.54125,"marketCap":1920909937},{"date":"2021-07-23","current":-26.077776,"twenty":-44.114079,"median":-31.592137,"eighty":-23.665789,"marketCap":1966107818},{"date":"2021-07-30","current":-27.512723,"twenty":-44.114079,"median":-31.182054,"eighty":-23.698533,"marketCap":2074294235},{"date":"2021-08-06","current":-24.030584,"twenty":-44.114079,"median":-30.212051,"eighty":-23.753397,"marketCap":1811761863},{"date":"2021-08-13","current":-21.870309,"twenty":-44.114079,"median":-29.959692,"eighty":-23.54125,"marketCap":1906675367},{"date":"2021-08-20","current":-22.754013,"twenty":-44.114079,"median":-29.298435,"eighty":-23.347286,"marketCap":1983717650},{"date":"2021-08-27","current":-23.087487,"twenty":-44.114079,"median":-29.147413,"eighty":-23.116438,"marketCap":2012790209},{"date":"2021-09-03","current":-24.526981,"twenty":-44.114079,"median":-28.763591,"eighty":-23.088599,"marketCap":2138286758},{"date":"2021-09-10","current":-27.250349,"twenty":-44.114079,"median":-28.571395,"eighty":-23.093045,"marketCap":2375712661},{"date":"2021-09-17","current":-27.761675,"twenty":-44.114079,"median":-28.455275,"eighty":-23.23224,"marketCap":2420290586},{"date":"2021-09-24","current":-27.322601,"twenty":-44.114079,"median":-28.343021,"eighty":-23.2583,"marketCap":2382011716},{"date":"2021-10-01","current":-25.544076,"twenty":-44.114079,"median":-28.29176,"eighty":-23.282013,"marketCap":2226958065},{"date":"2021-10-08","current":-23.459866,"twenty":-44.114079,"median":-28.051231,"eighty":-23.334399,"marketCap":2045254567},{"date":"2021-10-15","current":-24.393592,"twenty":-44.114079,"median":-27.830395,"eighty":-23.2583,"marketCap":2126657734},{"date":"2021-10-22","current":-25.071655,"twenty":-44.114079,"median":-27.795022,"eighty":-23.282013,"marketCap":2185771939},{"date":"2021-10-29","current":-24.68816,"twenty":-44.114079,"median":-27.614288,"eighty":-23.334399,"marketCap":2152338495},{"date":"2021-11-05","current":-25.093886,"twenty":-44.114079,"median":-27.51157,"eighty":-23.359824,"marketCap":2187710109},{"date":"2021-11-12","current":-22.592822,"twenty":-44.114079,"median":-27.502195,"eighty":-23.334399,"marketCap":2034009182},{"date":"2021-11-19","current":-20.767249,"twenty":-44.114079,"median":-27.472665,"eighty":-23.23224,"marketCap":1869654627},{"date":"2021-11-26","current":-19.79505,"twenty":-44.114079,"median":-27.303659,"eighty":-23.091933,"marketCap":1782128533},{"date":"2021-12-03","current":-18.369158,"twenty":-44.114079,"median":-27.153086,"eighty":-22.96936,"marketCap":1653756928},{"date":"2021-12-10","current":-18.563598,"twenty":-44.114079,"median":-27.062744,"eighty":-22.884983,"marketCap":1671262146},{"date":"2021-12-17","current":-16.981074,"twenty":-44.114079,"median":-27.03391,"eighty":-22.741786,"marketCap":1528789115},{"date":"2021-12-23","current":-18.028888,"twenty":-44.114079,"median":-26.966921,"eighty":-22.583934,"marketCap":1623122795},{"date":"2021-12-31","current":-17.391558,"twenty":-44.114079,"median":-26.945122,"eighty":-22.494611,"marketCap":1565744577},{"date":"2022-01-07","current":-14.642396,"twenty":-44.114079,"median":-26.76578,"eighty":-22.300169,"marketCap":1318240232},{"date":"2022-01-14","current":-14.874643,"twenty":-44.114079,"median":-26.661212,"eighty":-22.112495,"marketCap":1339149244},{"date":"2022-01-21","current":-12.638586,"twenty":-44.114079,"median":-26.481876,"eighty":-22.033675,"marketCap":1137839227},{"date":"2022-01-28","current":-12.060667,"twenty":-44.114079,"median":-26.289966,"eighty":-21.862451,"marketCap":1085809826},{"date":"2022-02-04","current":-12.363129,"twenty":-44.114079,"median":-26.215494,"eighty":-21.653569,"marketCap":1113040167},{"date":"2022-02-11","current":-12.768212,"twenty":-44.114079,"median":-26.189758,"eighty":-21.566139,"marketCap":1149509373},{"date":"2022-02-18","current":-11.315315,"twenty":-44.114079,"median":-26.126997,"eighty":-21.424043,"marketCap":1018706487},{"date":"2022-02-25","current":-13.222912,"twenty":-44.114079,"median":-26.111225,"eighty":-21.377925,"marketCap":1109296499},{"date":"2022-03-04","current":-12.502507,"twenty":-44.114079,"median":-26.025886,"eighty":-21.18172,"marketCap":1048860310},{"date":"2022-03-11","current":-13.577304,"twenty":-44.114079,"median":-25.985045,"eighty":-20.855769,"marketCap":1139027204},{"date":"2022-03-18","current":-14.082749,"twenty":-44.114079,"median":-25.918589,"eighty":-20.637754,"marketCap":1181430014},{"date":"2022-03-25","current":-14.431332,"twenty":-44.114079,"median":-25.843094,"eighty":-20.43022,"marketCap":1210673332},{"date":"2022-04-01","current":-14.559146,"twenty":-44.114079,"median":-25.792876,"eighty":-20.049774,"marketCap":1221395881},{"date":"2022-04-08","current":-6.576597,"twenty":-44.114079,"median":-25.612215,"eighty":-19.958878,"marketCap":551723917},{"date":"2022-04-14","current":-5.199695,"twenty":-44.114079,"median":-25.554817,"eighty":-19.864753,"marketCap":436212814},{"date":"2022-04-22","current":-5.327509,"twenty":-44.114079,"median":-25.544076,"eighty":-19.668627,"marketCap":446935364},{"date":"2022-04-29","current":-4.978926,"twenty":-44.114079,"median":-25.478287,"eighty":-19.254939,"marketCap":417692047},{"date":"2022-05-06","current":-4.351135,"twenty":-44.114079,"median":-25.362035,"eighty":-18.369158,"marketCap":411360615},{"date":"2022-05-13","current":-3.690464,"twenty":-44.114079,"median":-25.338376,"eighty":-17.947872,"marketCap":348900165},{"date":"2022-05-20","current":-3.442713,"twenty":-44.114079,"median":-25.267761,"eighty":-17.748031,"marketCap":325477497},{"date":"2022-05-27","current":-3.81434,"twenty":-44.114079,"median":-25.188455,"eighty":-17.278135,"marketCap":360611500},{"date":"2022-06-03","current":-3.576911,"twenty":-44.114079,"median":-25.18492,"eighty":-16.916261,"marketCap":338164776},{"date":"2022-06-10","current":-3.081408,"twenty":-44.114079,"median":-25.137996,"eighty":-16.247192,"marketCap":291319439},{"date":"2022-06-17","current":-2.771719,"twenty":-44.114079,"median":-25.071655,"eighty":-16.185052,"marketCap":262041103},{"date":"2022-06-24","current":-3.649172,"twenty":-44.114079,"median":-25.010518,"eighty":-16.185052,"marketCap":344996387},{"date":"2022-07-01","current":-4.144675,"twenty":-44.114079,"median":-24.952281,"eighty":-16.185052,"marketCap":391841724},{"date":"2022-07-08","current":-5.09955,"twenty":-44.114079,"median":-24.864068,"eighty":-16.076105,"marketCap":482116592},{"date":"2022-07-15","current":-5.171811,"twenty":-44.114079,"median":-24.834284,"eighty":-15.527673,"marketCap":488948204},{"date":"2022-07-22","current":-5.300848,"twenty":-44.114079,"median":-24.793744,"eighty":-14.607326,"marketCap":501147511},{"date":"2022-07-29","current":-4.975675,"twenty":-44.114079,"median":-24.729975,"eighty":-14.468514,"marketCap":470405258},{"date":"2022-08-05","current":-6.285699,"twenty":-44.114079,"median":-24.690939,"eighty":-14.087397,"marketCap":624628779},{"date":"2022-08-12","current":-6.054354,"twenty":-44.114079,"median":-24.58256,"eighty":-13.952612,"marketCap":601639309},{"date":"2022-08-19","current":-5.552286,"twenty":-44.114079,"median":-24.54541,"eighty":-13.60798,"marketCap":551747269},{"date":"2022-08-26","current":-5.389852,"twenty":-44.114079,"median":-24.502522,"eighty":-13.279847,"marketCap":535605726},{"date":"2022-09-02","current":-4.917317,"twenty":-44.114079,"median":-24.422547,"eighty":-13.222912,"marketCap":488648512},{"date":"2022-09-09","current":-5.527674,"twenty":-44.114079,"median":-24.375924,"eighty":-13.161536,"marketCap":549301580},{"date":"2022-09-16","current":-4.833639,"twenty":-44.114079,"median":-24.25892,"eighty":-12.914042,"marketCap":480333172},{"date":"2022-09-23","current":-4.213437,"twenty":-44.114079,"median":-24.190926,"eighty":-12.712041,"marketCap":418701828},{"date":"2022-09-30","current":-4.316804,"twenty":-44.114079,"median":-24.132625,"eighty":-12.529483,"marketCap":428973719},{"date":"2022-10-07","current":-3.799968,"twenty":-44.114079,"median":-24.099289,"eighty":-12.483741,"marketCap":377614265},{"date":"2022-10-14","current":-3.918102,"twenty":-44.114079,"median":-24.076584,"eighty":-12.283018,"marketCap":389353569},{"date":"2022-10-21","current":-4.28727,"twenty":-44.114079,"median":-24.062986,"eighty":-11.941843,"marketCap":426038893},{"date":"2022-10-28","current":-4.695816,"twenty":-44.114079,"median":-24.030584,"eighty":-10.868104,"marketCap":466637318},{"date":"2022-11-04","current":-4.090156,"twenty":-44.114079,"median":-23.861154,"eighty":-6.034665,"marketCap":436206932},{"date":"2022-11-11","current":-4.149833,"twenty":-44.114079,"median":-23.810013,"eighty":-5.915546,"marketCap":442571343},{"date":"2022-11-18","current":-4.448217,"twenty":-44.114079,"median":-23.778671,"eighty":-5.770615,"marketCap":474393397},{"date":"2022-11-25","current":-3.640285,"twenty":-44.114079,"median":-23.726602,"eighty":-5.724564,"marketCap":388229065},{"date":"2022-12-02","current":-3.929487,"twenty":-44.114079,"median":-23.660687,"eighty":-5.591663,"marketCap":419071979},{"date":"2022-12-09","current":-3.60356,"twenty":-44.114079,"median":-23.472492,"eighty":-5.517631,"marketCap":384312504},{"date":"2022-12-16","current":-3.378625,"twenty":-44.114079,"median":-23.398834,"eighty":-5.458763,"marketCap":360323571},{"date":"2022-12-23","current":-2.791038,"twenty":-44.114079,"median":-23.308206,"eighty":-5.432084,"marketCap":297658602},{"date":"2022-12-30","current":-2.708408,"twenty":-44.114079,"median":-23.247925,"eighty":-5.322177,"marketCap":288846341},{"date":"2023-01-06","current":-3.084831,"twenty":-44.114079,"median":-23.206892,"eighty":-5.253269,"marketCap":328991087},{"date":"2023-01-13","current":-3.920306,"twenty":-44.114079,"median":-23.093045,"eighty":-5.194735,"marketCap":418092839},{"date":"2023-01-20","current":-3.750457,"twenty":-44.114079,"median":-23.06953,"eighty":-5.163675,"marketCap":399978747},{"date":"2023-01-27","current":-3.59897,"twenty":-44.114079,"median":-22.94097,"eighty":-5.131545,"marketCap":383822934},{"date":"2023-02-03","current":-3.172051,"twenty":-44.114079,"median":-22.88689,"eighty":-5.083066,"marketCap":338292918},{"date":"2023-02-10","current":-2.703818,"twenty":-44.114079,"median":-22.859614,"eighty":-5.019294,"marketCap":288356771},{"date":"2023-02-17","current":-2.786447,"twenty":-44.114079,"median":-22.754013,"eighty":-4.976975,"marketCap":297169032},{"date":"2023-02-24","current":-2.039719,"twenty":-44.114079,"median":-22.672341,"eighty":-4.927157,"marketCap":261441035},{"date":"2023-03-03","current":-1.970836,"twenty":-44.114079,"median":-22.562574,"eighty":-4.849467,"marketCap":252611882},{"date":"2023-03-10","current":-1.676167,"twenty":-44.114079,"median":-22.507229,"eighty":-4.703692,"marketCap":214842727},{"date":"2023-03-17","current":-1.503958,"twenty":-44.114079,"median":-22.343925,"eighty":-4.561931,"marketCap":192769844},{"date":"2023-03-24","current":-1.35471,"twenty":-44.114079,"median":-22.294686,"eighty":-4.500165,"marketCap":173640012},{"date":"2023-03-31","current":-1.201636,"twenty":-44.114079,"median":-22.155834,"eighty":-4.489082,"marketCap":154019672},{"date":"2023-04-06","current":-1.163367,"twenty":-44.114079,"median":-22.047657,"eighty":-4.448217,"marketCap":149114587},{"date":"2023-04-14","current":-1.259039,"twenty":-44.114079,"median":-22.027723,"eighty":-4.385715,"marketCap":161377299},{"date":"2023-04-21","current":-1.251385,"twenty":-44.114079,"median":-21.883903,"eighty":-4.326648,"marketCap":160396282},{"date":"2023-04-28","current":-1.132752,"twenty":-44.114079,"median":-21.782732,"eighty":-4.277426,"marketCap":145190518},{"date":"2023-05-05","current":-1.206654,"twenty":-44.114079,"median":-21.654444,"eighty":-4.218359,"marketCap":158475948},{"date":"2023-05-12","current":-1.258955,"twenty":-36.670853,"median":-21.576478,"eighty":-4.168195,"marketCap":165344874},{"date":"2023-05-19","current":-1.187975,"twenty":-35.913777,"median":-21.558709,"eighty":-4.144675,"marketCap":156022759},{"date":"2023-05-26","current":-1.159957,"twenty":-35.274995,"median":-21.461892,"eighty":-4.067203,"marketCap":152342977},{"date":"2023-06-02","current":-1.255219,"twenty":-34.915384,"median":-21.393141,"eighty":-3.93316,"marketCap":164854236},{"date":"2023-06-09","current":-1.322463,"twenty":-34.497415,"median":-21.364494,"eighty":-3.896236,"marketCap":173685713},{"date":"2023-06-16","current":-1.348614,"twenty":-34.030552,"median":-21.229805,"eighty":-3.823631,"marketCap":177120177},{"date":"2023-06-23","current":-1.075902,"twenty":-33.882291,"median":-21.158302,"eighty":-3.803316,"marketCap":141303631},{"date":"2023-06-30","current":-1.027337,"twenty":-33.784502,"median":-20.906329,"eighty":-3.793106,"marketCap":134925342},{"date":"2023-07-07","current":-1.385971,"twenty":-33.6599,"median":-20.777553,"eighty":-3.762392,"marketCap":182026553},{"date":"2023-07-14","current":-1.359821,"twenty":-33.535298,"median":-20.637953,"eighty":-3.747883,"marketCap":178592090},{"date":"2023-07-21","current":-1.314992,"twenty":-33.499021,"median":-20.527778,"eighty":-3.714651,"marketCap":172704438},{"date":"2023-07-28","current":-1.359821,"twenty":-33.421737,"median":-20.411612,"eighty":-3.682206,"marketCap":178592090},{"date":"2023-08-04","current":-1.359821,"twenty":-33.35707,"median":-20.05326,"eighty":-3.645734,"marketCap":178592090},{"date":"2023-08-11","current":-1.206512,"twenty":-33.221427,"median":-19.983975,"eighty":-3.619865,"marketCap":168724632},{"date":"2023-08-18","current":-1.164301,"twenty":-33.186728,"median":-19.958393,"eighty":-3.599888,"marketCap":162821730},{"date":"2023-08-25","current":-1.125609,"twenty":-33.063703,"median":-19.865009,"eighty":-3.576196,"marketCap":157410736},{"date":"2023-09-01","current":-1.020083,"twenty":-32.920174,"median":-19.777483,"eighty":-3.521849,"marketCap":142653479},{"date":"2023-09-08","current":-0.819584,"twenty":-32.901247,"median":-19.668627,"eighty":-3.479616,"marketCap":114614692},{"date":"2023-09-15","current":-0.805514,"twenty":-32.830271,"median":-19.446679,"eighty":-3.456664,"marketCap":112647057},{"date":"2023-09-22","current":-0.770338,"twenty":-32.822385,"median":-19.103708,"eighty":-3.378625,"marketCap":107727972},{"date":"2023-09-29","current":-0.647225,"twenty":-32.735637,"median":-18.466378,"eighty":-3.313675,"marketCap":90511173},{"date":"2023-10-06","current":-0.576874,"twenty":-32.688319,"median":-18.089176,"eighty":-3.127862,"marketCap":80673002},{"date":"2023-10-13","current":-0.647225,"twenty":-32.577913,"median":-17.877657,"eighty":-3.038926,"marketCap":90511173},{"date":"2023-10-20","current":-0.650742,"twenty":-32.499051,"median":-17.758833,"eighty":-2.960887,"marketCap":91003081},{"date":"2023-10-27","current":-0.503006,"twenty":-32.344481,"median":-17.748031,"eighty":-2.912228,"marketCap":70342922},{"date":"2023-11-03","current":-0.510415,"twenty":-32.00222,"median":-17.45097,"eighty":-2.808882,"marketCap":68867197},{"date":"2023-11-10","current":-0.642841,"twenty":-31.73882,"median":-17.05669,"eighty":-2.77761,"marketCap":86734640},{"date":"2023-11-17","current":-0.664756,"twenty":-31.440722,"median":-16.819041,"eighty":-2.705654,"marketCap":89691503},{"date":"2023-11-24","current":-0.558833,"twenty":-31.208867,"median":-16.47337,"eighty":-2.645059,"marketCap":75400000},{"date":"2023-12-01","current":-0.595358,"twenty":-31.186786,"median":-16.185052,"eighty":-2.604603,"marketCap":80328104},{"date":"2023-12-08","current":-0.445605,"twenty":-31.101615,"median":-16.185052,"eighty":-2.340631,"marketCap":60122876},{"date":"2023-12-15","current":-1.829905,"twenty":-30.811403,"median":-16.185052,"eighty":-2.016758,"marketCap":246898040},{"date":"2023-12-20","current":-1.658237,"twenty":-30.571662,"median":-16.185052,"eighty":-1.987514,"marketCap":223735948},{"date":"2024-01-05","current":-2.315688,"twenty":-30.212051,"median":-16.185052,"eighty":-2.01253,"marketCap":312441831},{"date":"2024-01-12","current":-2.644413,"twenty":-30.00701,"median":-16.185052,"eighty":-2.016758,"marketCap":356794773},{"date":"2024-01-19","current":-3.054676,"twenty":-29.981774,"median":-16.185052,"eighty":-2.035127,"marketCap":412149116},{"date":"2024-01-26","current":-2.892031,"twenty":-29.950229,"median":-16.003474,"eighty":-2.042781,"marketCap":390204404},{"date":"2024-02-02","current":-2.937775,"twenty":-29.622163,"median":-15.817136,"eighty":-2.097627,"marketCap":396376354},{"date":"2024-02-09","current":-2.856453,"twenty":-29.347093,"median":-14.874643,"eighty":-2.265248,"marketCap":385403998},{"date":"2024-02-16","current":-4.015298,"twenty":-29.291179,"median":-14.60801,"eighty":-2.313305,"marketCap":541760069},{"date":"2024-02-23","current":-4.554803,"twenty":-29.246779,"median":-14.573671,"eighty":-2.328837,"marketCap":603479571},{"date":"2024-03-01","current":-5.685095,"twenty":-29.133218,"median":-14.431332,"eighty":-2.363901,"marketCap":753235345},{"date":"2024-03-08","current":-5.477988,"twenty":-29.040835,"median":-14.158276,"eighty":-2.442795,"marketCap":725795078},{"date":"2024-03-15","current":-4.923976,"twenty":-28.864995,"median":-14.06532,"eighty":-2.485894,"marketCap":652392362},{"date":"2024-03-22","current":-4.509761,"twenty":-28.73364,"median":-13.95784,"eighty":-2.48778,"marketCap":597511826},{"date":"2024-03-28","current":-4.168034,"twenty":-28.656761,"median":-13.802524,"eighty":-2.521115,"marketCap":552235385},{"date":"2024-04-05","current":-3.997171,"twenty":-28.552598,"median":-13.577304,"eighty":-2.58171,"marketCap":529597164},{"date":"2024-04-12","current":-4.033415,"twenty":-28.508631,"median":-13.357596,"eighty":-2.600072,"marketCap":534399211},{"date":"2024-04-19","current":-3.577779,"twenty":-28.461214,"median":-13.238108,"eighty":-2.606381,"marketCap":474030622},{"date":"2024-04-26","current":-3.230874,"twenty":-28.407377,"median":-13.222912,"eighty":-2.615503,"marketCap":428068174},{"date":"2024-05-03","current":-3.339204,"twenty":-28.365254,"median":-13.194899,"eighty":-2.628533,"marketCap":442421203},{"date":"2024-05-10","current":-3.711149,"twenty":-28.342534,"median":-12.999237,"eighty":-2.641387,"marketCap":467879344},{"date":"2024-05-17","current":-3.25817,"twenty":-28.323364,"median":-12.90324,"eighty":-2.64425,"marketCap":410770542},{"date":"2024-05-24","current":-3.039867,"twenty":-28.292549,"median":-12.774793,"eighty":-2.646141,"marketCap":383248228},{"date":"2024-05-31","current":-2.717871,"twenty":-28.243725,"median":-12.668292,"eighty":-2.65079,"marketCap":342652814},{"date":"2024-06-07","current":-2.575974,"twenty":-28.064133,"median":-12.546767,"eighty":-2.645277,"marketCap":324763309},{"date":"2024-06-14","current":-2.625092,"twenty":-28.051231,"median":-12.514126,"eighty":-2.641465,"marketCap":330955830},{"date":"2024-06-21","current":-2.210316,"twenty":-27.962905,"median":-12.490887,"eighty":-2.624311,"marketCap":278663433},{"date":"2024-06-28","current":-2.521398,"twenty":-27.920255,"median":-12.481954,"eighty":-2.621969,"marketCap":317882731},{"date":"2024-07-05","current":-2.483195,"twenty":-27.837978,"median":-12.357264,"eighty":-2.602826,"marketCap":313066326},{"date":"2024-07-12","current":-2.794277,"twenty":-27.822812,"median":-12.233156,"eighty":-2.598236,"marketCap":352285624},{"date":"2024-07-15","current":-3.083528,"twenty":-27.8217,"median":-12.200402,"eighty":-2.599154,"marketCap":388752690},{"date":"2024-08-02","current":-4.293917,"twenty":-27.820589,"median":-12.130534,"eighty":-2.600072,"marketCap":463176190},{"date":"2024-08-09","current":-3.721823,"twenty":-27.808361,"median":-11.92564,"eighty":-2.606381,"marketCap":401465589},{"date":"2024-08-16","current":-3.766819,"twenty":-27.781683,"median":-11.182988,"eighty":-2.615503,"marketCap":406319232},{"date":"2024-08-23","current":-3.895379,"twenty":-27.717212,"median":-6.576597,"eighty":-2.62275,"marketCap":420186783},{"date":"2024-08-30","current":-4.133216,"twenty":-27.621534,"median":-6.042048,"eighty":-2.627275,"marketCap":445841751},{"date":"2024-09-06","current":-3.747535,"twenty":-27.564992,"median":-6.005132,"eighty":-2.632349,"marketCap":404239099},{"date":"2024-09-13","current":-4.12036,"twenty":-27.512492,"median":-5.901764,"eighty":-2.639934,"marketCap":444454996},{"date":"2024-09-20","current":-4.223208,"twenty":-27.51157,"median":-5.829847,"eighty":-2.642,"marketCap":455549037},{"date":"2024-09-27","current":-4.004656,"twenty":-27.51014,"median":-5.75902,"eighty":-2.644195,"marketCap":431974201},{"date":"2024-10-04","current":-3.432562,"twenty":-27.50353,"median":-5.710007,"eighty":-2.644915,"marketCap":370263601},{"date":"2024-10-11","current":-3.40685,"twenty":-27.498236,"median":-5.690273,"eighty":-2.647284,"marketCap":367490090},{"date":"2024-10-18","current":-4.12036,"twenty":-27.487581,"median":-5.677328,"eighty":-2.65079,"marketCap":444454996},{"date":"2024-10-25","current":-3.824671,"twenty":-27.442652,"median":-5.626119,"eighty":-2.66206,"marketCap":412559630},{"date":"2024-10-31","current":-3.554694,"twenty":-27.322601,"median":-5.576897,"eighty":-2.67421,"marketCap":383437774},{"date":"2024-11-08","current":-4.041416,"twenty":-27.303659,"median":-5.55397,"eighty":-2.685456,"marketCap":426357312},{"date":"2024-11-15","current":-3.158193,"twenty":-27.250349,"median":-5.527674,"eighty":-2.693808,"marketCap":333179886},{"date":"2024-11-22","current":-2.683126,"twenty":-27.189212,"median":-5.508393,"eighty":-2.693808,"marketCap":283061725},{"date":"2024-11-29","current":-3.044445,"twenty":-27.13141,"median":-5.48589,"eighty":-2.69996,"marketCap":321179763},{"date":"2024-12-06","current":-2.609524,"twenty":-27.081617,"median":-5.458763,"eighty":-2.692138,"marketCap":275296940},{"date":"2024-12-13","current":-2.89055,"twenty":-27.064752,"median":-5.440135,"eighty":-2.69996,"marketCap":304944302},{"date":"2024-12-20","current":-2.572723,"twenty":-27.052761,"median":-5.432084,"eighty":-2.692138,"marketCap":271414547},{"date":"2024-12-27","current":-2.676435,"twenty":-27.045184,"median":-5.327509,"eighty":-2.675545,"marketCap":282355836},{"date":"2025-01-03","current":-2.448938,"twenty":-27.035488,"median":-5.300848,"eighty":-2.647646,"marketCap":258355589},{"date":"2025-01-10","current":-2.569377,"twenty":-27.014983,"median":-5.261873,"eighty":-2.644195,"marketCap":271061602},{"date":"2025-01-17","current":-2.58276,"twenty":-26.882894,"median":-5.187296,"eighty":-2.632349,"marketCap":272473381},{"date":"2025-01-24","current":-2.502466,"twenty":-26.634808,"median":-5.141598,"eighty":-2.621532,"marketCap":264002706},{"date":"2025-01-31","current":-2.46232,"twenty":-26.247738,"median":-5.09955,"eighty":-2.599154,"marketCap":259767369},{"date":"2025-02-07","current":-2.395409,"twenty":-26.184955,"median":-5.040373,"eighty":-2.577406,"marketCap":252708473},{"date":"2025-02-14","current":-2.141148,"twenty":-26.071078,"median":-4.978926,"eighty":-2.548458,"marketCap":225884668},{"date":"2025-02-21","current":-2.000635,"twenty":-25.979746,"median":-4.92406,"eighty":-2.506252,"marketCap":211060987},{"date":"2025-02-28","current":-1.742672,"twenty":-25.842094,"median":-4.893091,"eighty":-2.483297,"marketCap":183531293},{"date":"2025-03-07","current":-1.59079,"twenty":-25.555191,"median":-4.675276,"eighty":-2.452283,"marketCap":167535599},{"date":"2025-03-14","current":-1.361608,"twenty":-25.522929,"median":-4.602244,"eighty":-2.428865,"marketCap":143399115},{"date":"2025-03-21","current":-1.476199,"twenty":-25.354149,"median":-4.525936,"eighty":-2.4021,"marketCap":155467357},{"date":"2025-03-28","current":-1.240277,"twenty":-25.204311,"median":-4.496358,"eighty":-2.34188,"marketCap":130620976},{"date":"2025-04-04","current":-0.926837,"twenty":-25.165541,"median":-4.468151,"eighty":-2.27497,"marketCap":97610783},{"date":"2025-04-11","current":-0.815617,"twenty":-25.032749,"median":-4.416083,"eighty":-2.213591,"marketCap":85897489},{"date":"2025-04-17","current":-0.74147,"twenty":-24.931012,"median":-4.351259,"eighty":-2.130442,"marketCap":78088627},{"date":"2025-04-25","current":-1.085242,"twenty":-24.82155,"median":-4.299914,"eighty":-2.014017,"marketCap":114293354},{"date":"2025-05-02","current":-1.098723,"twenty":-24.693718,"median":-4.253466,"eighty":-1.970836,"marketCap":115713147},{"date":"2025-05-09","current":-1.058812,"twenty":-24.547165,"median":-4.226724,"eighty":-1.878991,"marketCap":109350907},{"date":"2025-05-16","current":-0.948805,"twenty":-24.451502,"median":-4.198758,"eighty":-1.787146,"marketCap":97989774},{"date":"2025-05-23","current":-0.94193,"twenty":-24.25892,"median":-4.166124,"eighty":-1.676167,"marketCap":97279703},{"date":"2025-05-30","current":-0.907553,"twenty":-24.159143,"median":-4.147254,"eighty":-1.637974,"marketCap":93729349},{"date":"2025-06-06","current":-1.010684,"twenty":-24.081605,"median":-4.130002,"eighty":-1.59079,"marketCap":104380412},{"date":"2025-06-13","current":-1.113815,"twenty":-24.044412,"median":-4.106078,"eighty":-1.476199,"marketCap":115031474},{"date":"2025-06-20","current":-0.990058,"twenty":-23.843342,"median":-4.08822,"eighty":-1.451071,"marketCap":102250199},{"date":"2025-06-27","current":-1.045061,"twenty":-23.753397,"median":-4.067203,"eighty":-1.407639,"marketCap":107930766},{"date":"2025-07-03","current":-1.017559,"twenty":-23.54125,"median":-4.054799,"eighty":-1.400167,"marketCap":105090482},{"date":"2025-07-11","current":-1.368205,"twenty":-23.367626,"median":-4.035069,"eighty":-1.385971,"marketCap":141304095},{"date":"2025-07-18","current":-1.498837,"twenty":-23.233302,"median":-4.004656,"eighty":-1.385971,"marketCap":154795440},{"date":"2025-07-25","current":-1.574467,"twenty":-23.073121,"median":-3.9918,"eighty":-1.385971,"marketCap":162606220},{"date":"2025-08-01","current":-1.409457,"twenty":-22.888243,"median":-3.934078,"eighty":-1.385971,"marketCap":145564520},{"date":"2025-08-08","current":-1.641841,"twenty":-22.766328,"median":-3.895379,"eighty":-1.381931,"marketCap":183198274},{"date":"2025-08-15","current":-1.498924,"twenty":-22.557757,"median":-3.86522,"eighty":-1.381931,"marketCap":167251415},{"date":"2025-08-22","current":-1.664762,"twenty":-22.330009,"median":-3.852653,"eighty":-1.381931,"marketCap":185755827},{"date":"2025-08-29","current":-1.626492,"twenty":-22.153744,"median":-3.819501,"eighty":-1.381931,"marketCap":181485578},{"date":"2025-09-05","current":-1.703033,"twenty":-21.962388,"median":-3.799968,"eighty":-1.381906,"marketCap":190026076},{"date":"2025-09-12","current":-1.741303,"twenty":-21.875747,"median":-3.786103,"eighty":-1.381931,"marketCap":194296324},{"date":"2025-09-19","current":-2.117628,"twenty":-21.875747,"median":-3.773247,"eighty":-1.381931,"marketCap":236287105},{"date":"2025-09-26","current":-1.396869,"twenty":-21.875747,"median":-3.752402,"eighty":-1.381931,"marketCap":155864084},{"date":"2025-10-03","current":-1.409626,"twenty":-21.859831,"median":-3.731057,"eighty":-1.381764,"marketCap":157287501},{"date":"2025-10-10","current":-1.537194,"twenty":-21.629231,"median":-3.715421,"eighty":-1.381764,"marketCap":171521664},{"date":"2025-10-17","current":-1.581843,"twenty":-21.54884,"median":-3.690464,"eighty":-1.377071,"marketCap":176503621},{"date":"2025-10-24","current":-1.518059,"twenty":-21.377925,"median":-3.680141,"eighty":-1.377071,"marketCap":169386539},{"date":"2025-10-31","current":-2.0518,"twenty":-21.160581,"median":-3.649466,"eighty":-1.377071,"marketCap":228941904},{"date":"2025-11-07","current":-1.86005,"twenty":-20.76931,"median":-3.631103,"eighty":-1.377071,"marketCap":221496639},{"date":"2025-11-14","current":-1.99394,"twenty":-20.527778,"median":-3.60356,"eighty":-1.377071,"marketCap":237440324},{"date":"2025-11-21","current":-1.93697,"twenty":-20.049774,"median":-3.576911,"eighty":-1.377071,"marketCap":230656314},{"date":"2025-11-28","current":-2.205541,"twenty":-19.958878,"median":-3.571427,"eighty":-1.377071,"marketCap":262638072},{"date":"2025-12-05","current":-2.107879,"twenty":-19.780996,"median":-3.545942,"eighty":-1.377071,"marketCap":251008342},{"date":"2025-12-12","current":-2.067186,"twenty":-19.428855,"median":-3.514973,"eighty":-1.377071,"marketCap":246162621},{"date":"2025-12-19","current":-1.635844,"twenty":-18.408046,"median":-3.484613,"eighty":-1.377071,"marketCap":194797980},{"date":"2025-12-26","current":-1.692814,"twenty":-17.794481,"median":-3.478843,"eighty":-1.377071,"marketCap":201581989},{"date":"2026-01-02","current":-1.554459,"twenty":-17.514703,"median":-3.463359,"eighty":-1.377071,"marketCap":185106538},{"date":"2026-01-09","current":-1.782338,"twenty":-16.988636,"median":-3.432562,"eighty":-1.377071,"marketCap":212242575},{"date":"2026-01-16","current":-1.806753,"twenty":-16.055325,"median":-3.396329,"eighty":-1.377071,"marketCap":215150007},{"date":"2026-01-23","current":-1.774199,"twenty":-15.45009,"median":-3.361864,"eighty":-1.377071,"marketCap":211273431},{"date":"2026-01-30","current":-1.595152,"twenty":-14.591474,"median":-3.334576,"eighty":-1.377071,"marketCap":189952259},{"date":"2026-02-06","current":-1.391688,"twenty":-14.229155,"median":-3.297574,"eighty":-1.377071,"marketCap":165723654},{"date":"2026-02-13","current":-1.489351,"twenty":-13.983984,"median":-3.271693,"eighty":-1.377071,"marketCap":177353384},{"date":"2026-02-20","current":-1.725368,"twenty":-13.678838,"median":-3.217321,"eighty":-1.377071,"marketCap":205458566},{"date":"2026-02-27","current":-2.262511,"twenty":-13.271714,"median":-3.151502,"eighty":-1.377071,"marketCap":269422082},{"date":"2026-03-06","current":-2.815988,"twenty":-13.204823,"median":-3.099901,"eighty":-1.377071,"marketCap":295661870},{"date":"2026-03-13","current":-2.555765,"twenty":-12.959258,"median":-3.067155,"eighty":-1.377071,"marketCap":268339981},{"date":"2026-03-20","current":-2.425653,"twenty":-12.712041,"median":-3.044445,"eighty":-1.377071,"marketCap":254679036},{"date":"2026-03-27","current":-2.434947,"twenty":-12.516333,"median":-3.00385,"eighty":-1.377071,"marketCap":255654818}],"updateTime":1774712027253},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CCCC\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2581060323","title":"C4 Therapeutics Showcases Progress on IKZF1/3 Degrader and Expanding Protein Degradation Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2581060323","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581060323?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:26","pubTimestamp":1762431987,"startTime":"0","endTime":"0","summary":"C4 Therapeutics Inc. has provided an update on its clinical and preclinical pipeline, highlighting progress in targeted protein degradation therapies. The company is advancing cemsidomide, an IKZF1/3 degrader, with completed Phase 1 dose escalation in multiple myeloma  and ongoing plans for Phase 2 trials in combination with dexamethasone. Data from Phase 1 studies in non-Hodgkin's lymphoma  and MM are expected to be presented at upcoming medical meetings. C4 Therapeutics also continues development of CFT8919 targeting EGFR L858R mutations and CFT1946 for BRAF V600 mutant solid tumors, while progressing early-stage programs through collaborations with Roche and MKDG. The company is building on a decade of experience in protein degradation to address a range of oncology and non-oncology indications. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to pr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL2PwNwc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CCCC"],"gpt_icon":0},{"id":"2581067514","title":"C4 Therapeutics Q3 EPS USD -0.44","url":"https://stock-news.laohu8.com/highlight/detail?id=2581067514","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581067514?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:14","pubTimestamp":1762431272,"startTime":"0","endTime":"0","summary":"Nov 06 (Reuters) - C4 Therapeutics Q3 revenue USD 11.2 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 06-NOV-202511:00:00.293 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nRSD7KQrwm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CCCC"],"gpt_icon":0},{"id":"2581620430","title":"C4 Therapeutics Q3 EPS $(0.44) Misses $(0.40) Estimate, Sales $11.230M Beat $6.280M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2581620430","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581620430?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:10","pubTimestamp":1762431012,"startTime":"0","endTime":"0","summary":"C4 Therapeutics (NASDAQ:CCCC) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.40) by 10.28 percent. This is a 25.71 percent decrease over losses of $(0.35) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48682595/c4-therapeutics-q3-eps-0-44-misses-0-40-estimate-sales-11-230m-beat-6-280m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CCCC"],"gpt_icon":0},{"id":"2581062299","title":"C4 Therapeutics Raises $125 Million and Reports Positive Phase 1 Cemsidomide Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2581062299","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581062299?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:09","pubTimestamp":1762430943,"startTime":"0","endTime":"0","summary":"C4 Therapeutics Inc. announced its third quarter 2025 financial results and recent business highlights. The company reported the completion of an equity offering that resulted in $125 million in gross proceeds, extending its financial runway to the end of 2028. There is also potential to earn up to an additional $225 million in proceeds. The company presented Phase 1 data of cemsidomide in combination with dexamethasone in multiple myeloma, showing a 40% overall response rate at the 75 g dose level and a 53% overall response rate at the 100 g dose level. One patient at the 100 g dose level achieved a minimal residual disease  negative complete response. Cemsidomide was reported to be well-tolerated with a differentiated safety and tolerability profile. C4 Therapeutics also entered into a clinical trial collaboration and supply agreement with Pfizer to evaluate cemsidomide in combination with elranatamab. The company plans to initiate a Phase 2 MOMENTUM trial in combination with dexamet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL7909rJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","LU1023059063.AUD","LU0058720904.USD","IE000M9KFDE8.USD","LU0306806265.USD","BK4599","BK4550","SG9999011175.SGD","LU1894683348.USD","SGXZ57979304.SGD","IE0002270589.USD","LU1894683264.USD","BK4581","IE00BLSP4452.SGD","LU0321505868.SGD","BK4139","CCCC","BK4592","BK4007","LU0225771236.USD","SG9999013999.USD","SG9999002224.SGD","SG9999002232.USD","LU1057294990.SGD","SG9999003800.SGD","BK4534","LU0456855351.SGD","LU0306807586.USD","SG9999001176.USD","LU0289739699.SGD","IE00B19Z3581.USD","LU1066051498.USD","BK4568","LU0122379950.USD","LU0985481810.HKD","LU0234572021.USD","LU0170899867.USD","LU0868494617.USD","BK4533","IE00BBT3K403.USD","IE00B19Z3B42.SGD","SG9999001176.SGD","IE00BLSP4239.USD","LU1883839398.USD","BK4585","LU0321505439.SGD","LU0225284248.USD","BK4588"],"gpt_icon":1},{"id":"2581674040","title":"C4 Therapeutics: Expects Current Cash, Cash Equivalents & Marketable Securities Will Enable Co to Fund Its Operating Plan to End of 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2581674040","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581674040?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:00","pubTimestamp":1762430408,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nPLX97AAD3:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CCCC","BK4139"],"gpt_icon":0},{"id":"2579849894","title":"C4 Therapeutics Inc  expected to post a loss of 40 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2579849894","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579849894?lang=en_us&edition=fundamental","pubTime":"2025-10-31 22:13","pubTimestamp":1761919987,"startTime":"0","endTime":"0","summary":"C4 Therapeutics Inc  expected to post a loss of40cents a share - Earnings Preview C4 Therapeutics Inc CCCC.OQ CCCC.O is expected to  show a fall in quarterly revenue when it reports  results on Novemb","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nL8N3WC1L9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CCCC","BK4139"],"gpt_icon":0},{"id":"2578464951","title":"C4 Therapeutics Inc  expected to post a loss of 40 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2578464951","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578464951?lang=en_us&edition=fundamental","pubTime":"2025-10-27 20:42","pubTimestamp":1761568955,"startTime":"0","endTime":"0","summary":"C4 Therapeutics Inc  expected to post a loss of40cents a share - Earnings Preview C4 Therapeutics Inc CCCC.OQ CCCC.O is expected to  show a fall in quarterly revenue when it reports  results on Octobe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nL8N3W80ZL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CCCC","BK4139"],"gpt_icon":0},{"id":"2577386891","title":"Point72 Asset Management Lp Reports 9.9% Passive Stake in C4 Therapeutics as of Oct 17 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2577386891","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577386891?lang=en_us&edition=fundamental","pubTime":"2025-10-21 06:16","pubTimestamp":1760998603,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nFWN3W12PI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CCCC","BK4139"],"gpt_icon":0},{"id":"2575748925","title":"C4 Therapeutics prices $125M underwritten offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2575748925","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575748925?lang=en_us&edition=fundamental","pubTime":"2025-10-16 19:20","pubTimestamp":1760613633,"startTime":"0","endTime":"0","summary":"C4 Therapeutics (CCCC) announced the pricing of an underwritten offering to a select group of institutional investors consisting of 21,895,000 shar...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/c4-therapeutics-prices-125m-underwritten-offering-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/c4-therapeutics-prices-125m-underwritten-offering-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CCCC","BK4139"],"gpt_icon":0},{"id":"2575435710","title":"C4 Therapeutics Announces $125 Million Underwritten Offering with Potential to Raise Up to $349.7 Million Through Stock and Warrant Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2575435710","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575435710?lang=en_us&edition=fundamental","pubTime":"2025-10-16 19:08","pubTimestamp":1760612912,"startTime":"0","endTime":"0","summary":"C4 Therapeutics Announces $125 Million Underwritten Offering with Potential to Raise Up to $349.7 Million Through Stock and Warrant Sales. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. C4 Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on October 16, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nNDLf67wD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU2210149790.SGD","BK4585","EVR","CCCC","BK4588","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU0314104364.USD","LU2095319765.USD","IE00B64PRP62.GBP","NDAQ","BK4139","IE00BKPKM429.USD","LU2210150020.SGD","BK4127"],"gpt_icon":0},{"id":"2575971048","title":"C4 Therapeutics Inc - Proceeds Could Reach $349.7 Mln IF All Warrants Exercised","url":"https://stock-news.laohu8.com/highlight/detail?id=2575971048","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575971048?lang=en_us&edition=fundamental","pubTime":"2025-10-16 19:08","pubTimestamp":1760612901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nTUA5TMLKN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CCCC"],"gpt_icon":0},{"id":"2575471049","title":"Press Release: C4 Therapeutics Announces Pricing of $125 Million Underwritten Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2575471049","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575471049?lang=en_us&edition=fundamental","pubTime":"2025-10-16 19:08","pubTimestamp":1760612880,"startTime":"0","endTime":"0","summary":"$125 Million in Upfront Proceeds Expected to Fund Next Phase of Cemsidomide Multiple Myeloma Development Including Registrational Phase 2 Trial in Combination with Dexamethasone and Phase 1b Trial in Combination with Elranatamab. Potential to Earn up to an Additional $225 Million in Proceeds. The offering was led by RA Capital Management with participation from existing shareholders including OrbiMed, Soleus Capital, Lynx1 Capital Management, and Bain Capital Life Sciences.All securities in the offering are being sold by C4T. The aggregate gross proceeds to C4T from the offering, before deducting underwriting discounts and commissions and offering expenses and excluding any proceeds from potential exercise of the Class A and Class B Warrants and nominal proceeds from potential exercise of the pre-funded warrants, are expected to be $125.0 million. If all Class A and Class B Warrants and pre-funded warrants are exercised, the aggregate gross proceeds to C4T from the offering, before ded","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4022","CCCC","USA","BK4139","R"],"gpt_icon":0},{"id":"2575710923","title":"C4 Therapeutics Presents Phase 1 Trial Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2575710923","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575710923?lang=en_us&edition=fundamental","pubTime":"2025-10-16 18:58","pubTimestamp":1760612316,"startTime":"0","endTime":"0","summary":"An announcement from C4 Therapeutics ( ($CCCC) ) is now available. On October 16, 2025, C4 Therapeutics announced the presentation of data from its...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/c4-therapeutics-presents-phase-1-trial-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/c4-therapeutics-presents-phase-1-trial-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CCCC","BK4139"],"gpt_icon":0},{"id":"2572537391","title":"C4 Therapeutics Showcases Pipeline Progress and Highlights Potential of Cemsidomide and Next-Generation Degrader Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2572537391","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572537391?lang=en_us&edition=fundamental","pubTime":"2025-10-01 22:09","pubTimestamp":1759327750,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. C4 Therapeutics Inc. published the original content used to generate this news brief on October 01, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nNDL4hLnsP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001176.USD","BK4550","LU0456855351.SGD","IE000M9KFDE8.USD","BK4588","CCCC","LU0234572021.USD","LU0321505868.SGD","LU0122379950.USD","LU0868494617.USD","LU1023059063.AUD","SG9999013999.USD","SG9999003800.SGD","IE00B19Z3581.USD","LU1066051498.USD","BK4139","BK4534","LU0321505439.SGD","LU0306806265.USD","SGXZ57979304.SGD","BK4568","LU0225771236.USD","IE00B19Z3B42.SGD","IE0002270589.USD","LU0170899867.USD","LU1066053197.SGD","LU1894683264.USD","IE00BLSP4452.SGD","BK4599","BK4533","IE00BBT3K403.USD","LU0289739699.SGD","SG9999001176.SGD","BK4007","LU0985481810.HKD","BK4585","SG9999002232.USD","LU1057294990.SGD","SG9999002224.SGD","LU1883839398.USD","SG9999011175.SGD","LU1894683348.USD","IE00BLSP4239.USD","LU0058720904.USD","BK4592","BK4581","LU0306807586.USD","LU0225284248.USD"],"gpt_icon":1},{"id":"2572556536","title":"BUZZ-C4 Therapeutics climbs after partnership with Pfizer for cancer therapy trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2572556536","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572556536?lang=en_us&edition=fundamental","pubTime":"2025-10-01 19:50","pubTimestamp":1759319430,"startTime":"0","endTime":"0","summary":"BUZZ-C4 Therapeutics climbs after partnership with Pfizer for cancer therapy trial** Shares of drug developer C4 Therapeutics CCCC.O rise 8% to $2.40 premarket** Co says it has partnered with Pfizer PFE.N to test a combination therapy for cancer** CCCC will test its drug cemsidomide with Pfizer's elranatamab in patients with multiple myeloma, a type of blood cancer, who have already received at least one prior treatment** Under the deal, Pfizer will supply elranatamab, sold under the brand name Elrexfio, at no cost, while C4 Therapeutics will lead and sponsor the early-stage trial, which is expected to begin in Q2 of 2026** As of last close, stock down 38% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ffe7a2a2d678bb186cf960f845d09a05","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nL3N3VI0UF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999011175.SGD","LU1894683348.USD","IE00BLSP4452.SGD","LU1066053197.SGD","BK4550","LU0868494617.USD","LU1066051498.USD","IE00BLSP4239.USD","LU0225284248.USD","BK4534","LU0321505439.SGD","LU0985481810.HKD","BK4581","SGXZ57979304.SGD","BK4588","SG9999013999.USD","LU0289739699.SGD","LU0225771236.USD","SG9999001176.USD","BK4599","IE00B19Z3B42.SGD","CCCC","BK4007","LU0170899867.USD","BK4568","BK4533","IE00B19Z3581.USD","LU0321505868.SGD","SG9999002232.USD","LU0122379950.USD","IE0002270589.USD","LU0456855351.SGD","LU0234572021.USD","LU0306806265.USD","BK4592","SG9999001176.SGD","LU1894683264.USD","LU1057294990.SGD","SG9999002224.SGD","IE000M9KFDE8.USD","LU0306807586.USD","BK4585","LU1883839398.USD","IE00BBT3K403.USD","LU0058720904.USD","SG9999003800.SGD","BK4139","LU1023059063.AUD"],"gpt_icon":1},{"id":"2572535319","title":"C4 Therapeutics announces trial collab, supply agreement with Pfizer","url":"https://stock-news.laohu8.com/highlight/detail?id=2572535319","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572535319?lang=en_us&edition=fundamental","pubTime":"2025-10-01 19:10","pubTimestamp":1759317058,"startTime":"0","endTime":"0","summary":"C4 Therapeutic (CCCC) announced that it has entered into a clinical trial collaboration and supply agreement with Pfizer (PFE). Under the terms of ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/c4-therapeutics-announces-trial-collab-supply-agreement-with-pfizer-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/c4-therapeutics-announces-trial-collab-supply-agreement-with-pfizer-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1883839398.USD","BK4550","BK4592","LU0225284248.USD","SG9999002224.SGD","SGXZ57979304.SGD","LU0225771236.USD","IE00B19Z3581.USD","BK4534","BK4599","LU0170899867.USD","LU1066053197.SGD","SG9999001176.USD","LU0868494617.USD","BK4007","LU1894683348.USD","LU0306806265.USD","LU1023059063.AUD","BK4588","LU0306807586.USD","IE00BBT3K403.USD","LU0058720904.USD","SG9999003800.SGD","BK4533","LU1894683264.USD","PFE","IE00BLSP4239.USD","LU0289739699.SGD","LU1057294990.SGD","LU1066051498.USD","LU0321505439.SGD","SG9999002232.USD","IE0002270589.USD","SG9999011175.SGD","LU0985481810.HKD","LU0321505868.SGD","BK4585","SG9999001176.SGD","BK4139","SG9999013999.USD","CCCC","LU0456855351.SGD","BK4568","IE00B19Z3B42.SGD","LU0122379950.USD","IE000M9KFDE8.USD","LU0234572021.USD","IE00BLSP4452.SGD","BK4581"],"gpt_icon":0},{"id":"2572533653","title":"C4 Therapeutics Announces Clinical Trial Collaboration with Pfizer to Combine Cemsidomide and Elranatamab for Multiple Myeloma Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2572533653","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572533653?lang=en_us&edition=fundamental","pubTime":"2025-10-01 19:00","pubTimestamp":1759316415,"startTime":"0","endTime":"0","summary":"C4 Therapeutics Announces Clinical Trial Collaboration with Pfizer to Combine Cemsidomide and Elranatamab for Multiple Myeloma Treatment. C4 Therapeutics Inc. has announced a clinical trial collaboration and supply agreement with Pfizer Inc. to evaluate a new treatment combination for relapsed or refractory multiple myeloma. Under the agreement, Pfizer will supply its BCMAxCD3 bispecific antibody, elranatamab , for use in an upcoming Phase 1b clinical trial sponsored by C4 Therapeutics. The trial will assess the safety and tolerability of combining cemsidomide, an IKZF1/3 degrader, and dexamethasone with elranatamab as a second-line or later therapy. The collaboration aims to identify an optimal dose for the combination and explore its potential to improve patient outcomes in multiple myeloma. The trial is expected to begin in the second quarter of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provid","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ffe7a2a2d678bb186cf960f845d09a05","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nNDLb9p9YV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","LU0122379950.USD","IE00BLSP4452.SGD","LU2210150020.SGD","LU0234572021.USD","LU1066051498.USD","BK4581","BK4112","BK4568","IE00BGHQF748.EUR","LU0321505868.SGD","CCCC","BK4592","SG9999002232.USD","LU0225284248.USD","LU0306807586.USD","IE00B3QW5Z07.USD","LU0058720904.USD","LU1057294990.SGD","BK4533","BK4534","LU1894683348.USD","BK4588","IE00BLSP4239.USD","SG9999011175.SGD","SG9999001176.USD","IE00B19Z3B42.SGD","LU0314104364.USD","BK4550","IE0002270589.USD","IE00B64PRP62.GBP","LU1894683264.USD","LU0456855351.SGD","LU2095319765.USD","PFE","LU2210149790.SGD","BK4585","NDAQ","IE00BKPKM429.USD","LU0985481810.HKD","SG9999001176.SGD","LU0321505439.SGD","IE000M9KFDE8.USD","SGXZ57979304.SGD","IE00BBT3K403.USD","BK4139","LU0868494617.USD","LU0289739699.SGD","BK4007","SG9999003800.SGD"],"gpt_icon":1},{"id":"2572533903","title":"C4 Therapeutics Inc - Pfizer to Supply Elranatamab at No Cost; C4t to Conduct Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2572533903","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572533903?lang=en_us&edition=fundamental","pubTime":"2025-10-01 19:00","pubTimestamp":1759316400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ffe7a2a2d678bb186cf960f845d09a05","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nTUA88N31J:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4550","LU0122379950.USD","LU0306807586.USD","LU0985481810.HKD","IE00B19Z3B42.SGD","LU1066051498.USD","PFE","LU1066053197.SGD","SG9999011175.SGD","SG9999013999.USD","BK4139","IE00BLSP4239.USD","LU1023059063.AUD","BK4568","LU0321505439.SGD","IE00B19Z3581.USD","BK4592","IE0002270589.USD","IE00BLSP4452.SGD","SG9999002224.SGD","SGXZ57979304.SGD","BK4007","SG9999003800.SGD","LU0868494617.USD","LU0170899867.USD","IE00BBT3K403.USD","BK4585","LU1057294990.SGD","LU1894683264.USD","LU0289739699.SGD","LU1883839398.USD","LU0225284248.USD","LU0456855351.SGD","SG9999001176.SGD","LU0321505868.SGD","LU1894683348.USD","SG9999002232.USD","BK4581","BK4533","SG9999001176.USD","IE000M9KFDE8.USD","LU0058720904.USD","LU0225771236.USD","CCCC","BK4588","BK4599","BK4534","LU0306806265.USD","LU0234572021.USD"],"gpt_icon":0},{"id":"2572533692","title":"C4 Therapeutics Announces Clinical Trial Collaboration and Supply Agreement With Pfizer for the Combination of Cemsidomide and Elranatamab for the Treatment of Relapsed/Refractory Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2572533692","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572533692?lang=en_us&edition=fundamental","pubTime":"2025-10-01 19:00","pubTimestamp":1759316400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ffe7a2a2d678bb186cf960f845d09a05","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nTUA88N31J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CCCC","BK4139"],"gpt_icon":0},{"id":"2571704334","title":"CCCC Lisbon 2025 Announces Bybit EU and Top Partners as Sponsors of Its Third Global Edition","url":"https://stock-news.laohu8.com/highlight/detail?id=2571704334","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571704334?lang=en_us&edition=fundamental","pubTime":"2025-09-29 22:00","pubTimestamp":1759154400,"startTime":"0","endTime":"0","summary":"LISBON, Portugal, Sept. 29, 2025 /PRNewswire/ -- The Crypto Content Creator Campus , the global summit at the intersection of content, crypto, and creator monetization, welcomes Bybit EU and other leading industry players as official sponsors of its 2025 edition, taking place in Lisbon from 14 - 16 November 2025.The addition of two of the world's leading exchanges reflects growing support for creator-led Web3 adoption and further solidifies Lisbon's position as a hub for innovation. According to Greenfield Capital's State of European Crypto report, Lisbon ranks as Europe's leading crypto hub, driven by its strong DeFi ecosystem and favourable tax policies.CCCC is a team of industry experts and visionaries committed to shaping the future of content creation within the Web3 and crypto sphere. Driven by a shared passion for creating a high-value community, we've curated a campus that promises an experience unlike any other. The CCCC 2025 will be held in Lisbon, Portugal, from November 14 ","market":"other","thumbnail":"https://mma.prnewswire.com/media/2753618/Crypto_Content_Creator_Campus_NEW_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2753618/Crypto_Content_Creator_Campus_NEW_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/cccc-lisbon-2025-announces-bybit-eu-and-top-partners-as-sponsors-of-its-third-global-edition-302569414.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CCCC","BK4156","TON.USD.HKCC","BK4139","BGA.AU","BK6509","APT.USD.HKCC","TON.USD.CC","BK7141","APT.USD.CC","5HG.SI","BK6095","BK7505"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":60,"code":"91000000","status":"200"}]}}